| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REGULAR ARTICLES |
Department of Integrative Biology and Pharmacology, University of Texas-Houston Health Science Center, Houston, Texas.
Correspondence to Roger G. O'Neil, The University of Texas-Houston Health Science Center, Department of Integrative Biology, Pharmacology, and Physiology, 6431 Fannin, Houston, TX 77030. Phone : 713-500-6316 ; Fax : 713-500-7444 ; E-mail roneil{at}girch1.med.uth.tmc.edu
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The mechanism by which high glucose levels may depress calcium signals generated by vasoactive peptides is unknown (see Discussion). The generation of Ca2+ signals is a complicated process involving several Ca2+ transport components for Ca2+ influx and Ca2+ release from internal stores. Initial studies evaluating the release of Ca2+ from stores did not find a major effect of glucose in modulating Ca2+ release (10). Recently, Mene and coworkers (11 presented evidence consistent with the view that chronic high glucose levels may modulate a store-operated Ca2+ influx pathway (SOCI ; also known as capacitative Ca2+ entry), which is activated by Ca2+ store depletion 13,14,15). However, the extent to which this pathway or other parallel entry pathways contribute to the change in the glucose-modulated Ca2+ signal remains largely unknown.
In mesangial cells, many vasoactive peptides that induce Ca2+ signals normally do so through G protein-linked receptors that are coupled to phospholipase C (PLC), resulting in the generation of inositol trisphosphate (IP3) and diacylglycerol (DAG) (16,17,18,19). The IP3, in turn, binds to IP3 receptors on the endoplasmic reticulum (ER) (ER Ca2+ release channels) to activate release of Ca2+ from the ER stores into the cytoplasm. A second critical component to the calcium signal, however, is induction of Ca2+ entry via plasma membrane Ca-permeable channels. The binding of vasoactive peptides to their plasma membrane receptors can directly lead to activation of receptor-operated Ca2+ channels a through various transduction pathways or, if membrane voltage is altered, to activation of voltage-operated Ca2+ channels (20,21). Alternatively, the IP3- induced release of Ca2+ from the ER can indirectly activate plasma membrane Ca2+ entry via SOCI pathways due to unloading (release) of Ca2+ from stores (13,14,15). Although SOCI has been shown to reside in mesangial cells 22,23), the mechanism linking the unloading of Ca2+ stores to activation of SOCI remains unknown. High glucose levels could potentially modify one or more of these Ca2+ transport pathways.
The purpose of the present study was to determine : (1) whether Ca2+ signaling induced by the potent vasoactive hormone endothelin-1 (ET) in mesangial cells is modulated by acute elevation in plasma glucose levels ; (2) if modulated, which underlying components of the Ca2+ signal are being modulated ; and (3) whether the ET-induced Ca2+ signaling components undergo adaptation to prolonged (chronic) exposure to high glucose levels. It was found that ET induces release of Ca2+ from stores and activates Ca2+ influx through both SOCI pathways and other parallel entry pathways (supposedly receptor-operated Ca2+ entry since ET does not activate voltage-operated Ca2+ channels in mesangial cells) (24). Both acute and chronic elevation in glucose levels were found to markedly depress the ET-induced Ca2+ signal. However, this effect was not due to depression of Ca2+ release from stores or inhibition of SOCI, but rather to specific depression of a non-store-operated Ca2+ entry pathway, likely a receptor-operated Ca2+ entry pathway.
| Materials and Methods |
|---|
|
|
|---|
Measurement of Intracellular Calcium
Confluent primary cultures of mesangial cells were rinsed twice with
Dulbecco's phosphate-buffered saline and detached by mild trypsinization
(0.05% trypsin plus 0.53 mM ehtylenediaminetetra-acetic acid) for 2 to 3 min.
The reaction was stopped by addition of the old medium. The detached cells
were rinsed once with isotonic bathing media and resuspended in the fresh
isotonic bathing media (see Solutions and Chemicals). Fura-2 was loaded into
the cells by incubation of the cells in isotonic bathing media containing 10
µM acetoxymethyl ester of fura-2 (fura-2 AM) for 30 min at 37°C with
periodic mild mixing. At the end of the initial 30-min incubation, the mixture
of cells and fura 2 AM was diluted 1 : 4 by addition of isotonic bathing media
and incubated for another 60 min. The cells were then rinsed with the isotonic
bathing media without fura-2 AM, resuspended in the isotonic bathing media,
and kept at room temperature until use. Just before use, the cells were rinsed
twice, and an aliquot of cells was added to a cuvette containing 2 ml of test
solution for measurement of intracellular Ca2+. The test solution
was isotonic bathing media (310 mosmol/kg H2O) with or without 5 mM
ethyleneglycolbis(ß-aminoethyl ether)-N,N,N',N'-tetra-acetic
acid (EGTA) (see Solutions and Chemicals, below).
Intracellular calcium was estimated from the fura-2 fluorescence by
excitation at 340 and 380 nm and obtaining the resulting ratio of the emission
at 511 nm in the usual manner at 37°C, using a Delta Scan dual excitation
fluorometer (Photon Technology International, South Brunswick, NJ) similar to
that described before (25).
All fluorescence measurements were initiated when the cells were added to the
cuvette. Fura-2 fluorescence ratios were converted to intracellular calcium
activity ([Ca2+]i) using the formula described by
Grynkiewicz et al.
(26) as follows :
![]() |
where R is the ratio at any time, ß is the ratio of the fluorescence emission intensity at 380 nm excitation in Ca2+-depleting and Ca2+-saturating conditions, Kd is the Ca2+ dissociation constant of fura-2 (Kd = 224 nM), Rmin is the minimum ratio in Ca2+-depleting conditions (addition of 5 mM EGTA), and Rmax is the maximum ratio in Ca2+-saturating conditions (0.1% Triton X-100 in normal bathing medial containing 1 mM Ca2+).
Treatment Groups
The control glucose group of mesangial cells was cultured in control media
containing 5 mM glucose for 5 to 7 d (chronic) and then tested (acute) in the
presence of 5 mM glucose (chronic : acute treatment ; 5G : 5G). The chronic
high glucose group was cultured in media containing 30 mM glucose for 5 to 7 d
and tested in 30 mM glucose (30G : 30G), while the chronic group's osmolarity
control was similarly cultured in media containing 5 mM glucose + 25 mM
mannitol and tested in 5 mM glucose + 25 mM mannitol (5G + 25M : 5G + 25M).
The acute high glucose group of mesangial cells was cultured in media
containing 5 mM glucose and tested in 30 mM glucose (5G : 30G), while the
acute group's osmolarity control was cultured in media containing 5 mM glucose
and tested in media containing 5 mM glucose + 25 mM mannitol (5G : 5G + 25M).
To test whether the effects of chronic high glucose were reversible, a final
group of cells was cultured in 30 mM glucose and tested in 5 mM glucose (30G :
5G).
Solutions and Chemicals
The tissue culture medium used for all studies was Waymouth medium,
containing 16% heat-inactivated fetal bovine serum, penicillin (100 U/ml),
streptomycin (100 µg/ml), gentamicin (25 µg/ml), human transferrin (10
µg/ml), hydrocortisone (5 x 10 to 8 M), and insulin (5 µg/ml), 25
mM NaHCO3, pH 7.4. The following experimental solutions were used
for measurements of intracellular calcium. The isotonic bathing solution was
composed of (in mM) : 140 NaCl, 4.2 KCl, 0.4 Na2-HPO4,
0.5 NaH2PO4, 0.3 MgCl2, 0.4 MgSO4,
1 CaCl2-H2O, 20 Hepes, pH 7.4, at 37°C. Just before
use, 0.2% bovine serum albumin (BSA) and 5 or 30 mM glucose, or 5 mM glucose
plus 25 mM mannitol were added to the solution for each of the treatment
groups as outlined above (see Treatment Groups). The osmolalities of all
solutions were determined using a vapor-pressure osmometer (Wescor, Logan,
UT). In some studies, the bathing media Ca2+ levels were reduced to
nominally zero by the removal of Ca2+ and addition of 5 mM EGTA to
the bathing media (pH 7.4).
The chemicals and drugs used in the study were as follows. Fura-2 free acid and fura-2 AM were obtained from Calbiochem (La Jolla, Ca). Tissue culture supplements were obtained from Life Technologies (Grand Island, NY) and JRH Biosciences (Lenexa, KS). Thapsigargin (TG), ET, and all other reagents were obtained from Sigma Chemical Co. (St. Louis, MO).
Statistical Analyses
Data are expressed as mean values ± SEM ; n is the number
of replicates. Significance was determined with the paired or unpaired
t test as appropriate, or, for multiple comparison, ANOVA and
Student-Neumann-Keuls post hoc test as appropriate. A value of P <
0.05 was considered significant.
| Results |
|---|
|
|
|---|
Figure 1A (top trace) depicts a typical example of ET-induced Ca2+ signaling for cells cultured and tested in the presence of normal glucose levels (5 mM). Addition of ET (10 nM) produces an immediate rise in intracellular Ca2+ from a basal level of near 140 nM to a peak value of more than 550 nM, followed by relaxation of the intracellular Ca2+ levels to a pseudoplateau greater than that observed during the basal resting conditions. On average, the ET-induced peak response was 575 ± 76 nM (Table 1A, 5G : 5G group).
|
|
To assess the fraction of the Ca2+ signal that may be due to Ca2+ release from internal stores, the study was repeated with extracellular Ca2+ levels reduced to nominally zero levels (-Ca2+) by the addition of the Ca2+ chelator EGTA. Removal of extracellular Ca2+ appeared to modestly depress the basal Ca2+ levels, although on average the change was not significantly different from the control values with extracellular Ca2+ present (Table 1). As shown by the example in Figure 1A (bottom trace), in the absence of extracellular Ca, ET produced a depressed Ca2+ signal whose peak value averaged only 239 ± 73 nM (Table 1A, 5G : 5G group). The Ca2+ signal reflects release of Ca2+ from internal Ca2+ stores. The difference between the peak Ca2+ signal in the presence and absence of extracellular Ca2+ will primarily delineate initial influx of Ca2+ across the plasma membrane. Hence, based on these results, it follows that although part of the ET-induced rise in intracellular Ca2+ is due to release of Ca2+ from stores, a major fraction of the rise in intracellular Ca2+ must be due to activation of Ca2+ influx across the plasma membrane.
Calcium Stores and SOCI in Mesangial Cells
The potential involvement of SOCI in Ca2+ signaling in mesangial
cells was evaluated in a parallel series of experiments by assessing the
effects of TG, a specific inhibitor of the ER Ca2+-ATPase, to
unload ER Ca2+ stores. A concentration of 1 µM TG was shown to
maximally empty internal stores (data not shown). As shown by the example in
Figure 1B (top trace), addition
of TG induces a rise in intracellular Ca2+ to a peak value within 1
min that then relaxes to a new pseudoplateau value modestly greater than that
observed in the basal state. For all cells, the peak Ca2+ value
averaged near 470 nM (Table 1B,
5G : 5G group). Repeating the experiments in the absence of extracellular
Ca2+ (-Ca2+) resulted in a depressed signal
(Figure 1B, bottom trace) that
averaged near 235 nM for all cells (Table
1), reflecting release of Ca2+ from stores. Hence, the
unloading of stores by TG in the presence of extracellular Ca2+
induces Ca2+ influx, which accounts for the enhanced peak
Ca2+ signal compared to that observed in the absence of
extracellular Ca. This induced Ca2+ influx reflects typical SOCI
(14). It follows that
Ca2+ influx via SOCI must also be a component of the ET-induced
Ca2+ influx because ET also causes release of Ca2+ from
ER stores. Furthermore, because the ET-induced Ca2+ peak in the
presence of extracellular Ca2+ (575 nM) tends to be greater than
that observed for the TG-induced peak (470 nM), although not significantly
greater, the ET-induced Ca2+ peak likely reflects the contributions
of additional Ca influx pathways stimulated by ET (see below).
Acute High Glucose Effects on ET-Induced Ca2+ Signaling
Pathways
To test the effects of elevated glucose on the ET-induced influx and
release of Ca2+, mesangial cells were cultured in varying
concentrations of glucose or glucose plus mannitol (osmotic control) for 5 to
7 d before use (see Materials and Methods). To determine the acute affects of
high glucose levels, cells were cultured in normal glucose (5 mM) and tested
with ET in high glucose (30 mM) (5G : 30G group). As shown by the example in
Figure 2A, with acute high
glucose levels the ET-induced peak Ca2+ signal in the presence of
extracellular Ca only reached a value of approximately 350 nM, well below that
observed in the presence of normal glucose levels (compare to
Figure 1A). In all cases, the
acute high glucose group (5G : 30G) demonstrated a significantly depressed
ET-induced Ca2+ signal compared to that observed for the normal
glucose group (5G : 5G). The ET-induced peak Ca2+ signal averaged
335 nM (change = 188 ± 42) with acute high glucose (5G : 30G group)
compared to 575 nM (change = 445 ± 61) observed for the normal glucose
control group (5G : 5G group) (see Table
1A and Figure
3A).
|
|
In a parallel series of studies, the effect of acute high glucose levels on ET-induced release of Ca from Ca stores was also assessed in cells in which the extracellular Ca was removed. A representative trace showing the ET-induced release of Ca from internal stores in cells exposed to acute high glucose levels (5G : 30G group) in the absence of extracellular Ca (-Ca) is shown in Figure 2A. In the absence of extracellular Ca, the observed changes in intracellular Ca levels for the acute high glucose conditions are very similar to that observed for cells exposed to normal glucose levels (5G : 5G, compare with Figure 1A). On average, the change in intracellular Ca levels between the two groups was not significantly different. In the absence of extracellular Ca2+ (-Ca), the ET-induced release of Ca2+ from internal stores produced a change in intracellular Ca of 156 ± 67 nM Ca for the normal glucose group and a change of 122 ± 19 for the acute high glucose group (Figure 3B).
Chronic High Glucose Effects on ET-Induced Ca2+ Signaling
Pathways
Figure 4A shows typical
traces demonstrating the effects of ET on Ca2+ signaling in cells
chronically cultured in, and then tested in, high glucose media (30G : 30G).
As demonstrated by the representative example shown in
Figure 4A, in cells treated
with chronic high glucose levels the ET-induced Ca2+ signal was
markedly depressed in the presence of extracellular Ca2+, with the
peak Ca2+ signal approaching a value of only 250 nM. On average,
the ET-induced Ca2+ peak was only 313 ± 84 nM
(Table 2A, 30G : 30G group),
significantly below the peak of 575 ± 76 nM observed for the normal
glucose group (Table 2A, 5G :
5G group). This depressant affect of chronic high glucose was not due to
alterations in bathing media osmolality, as the peak Ca2+ signal
was not depressed in cells in which the chronic high glucose was substituted
for mannitol (Figure 5A, 5G +
25M : 5G + 25 M group). Hence, chronic high glucose levels markedly depress
the ET-induced Ca signal in these cells, similar to that observed for the
affects of acute high glucose levels.
|
|
|
Finally, the affects of chronic high glucose levels on ET-induced release of Ca from internal stores was also assessed. A representative example showing the ET-induced release of Ca from stores in cells in which extracellular Ca2+ was first removed (-Ca) is shown in Figure 4A. Although there was a tendency for the Et-induced change in intracellular Ca to be depressed in the chronic high glucose group from that observed in the normal glucose group, the change was not significantly different (see Figure 5B and Table 2A). On average, in the absence of extracellular Ca the ET-induced change in intracellular Ca levels averaged 156 ± 67 nM for the normal glucose group (5G : 5G) and 61 ± 15 nM for the chronic high glucose group (30G : 30G).
Acute High Glucose Effects on Ca2+ Stores and SOCI
To further extend our assessment of the influence of high glucose levels on
Ca stores and SOCI, the effects of treating mesangial cells with TG to
completely release Ca from TG-sensitive ER Ca stores was studied. The
difference in the rise in [Ca2+]i after the addition of
TG with and without extracellular calcium would, by definition, represent SOCI
(13,14,15).
As shown by the summary data in Figure 6, A and B, the TG-induced peak changes in intracellular Ca2+ levels in the presence or absence of extracellular Ca2+ were not affected by acute high glucose levels. In the presence of extracellular Ca, the TG-induced rise (change) in intracellular Ca2+ levels average near 300 nM for both the acute high glucose group (5G : 30G group) and the normal glucose group (5G : 5G group). Similarly, in the absence of extracellular Ca2+ (-Ca2+), the TG-induced rise in intracellular Ca2+ levels averaged near 130 nM for both the acute high glucose group (5G : 30G group) and the normal glucose group (5G : 5G group). Hence, acute high glucose levels do not appear to alter the Ca ER stores or release of Ca from these stores.
|
Chronic High Glucose Effects on Ca2+ Stores and SOCI
Figure 4B shows an example
of the effects of TG for a chronic high glucose group with and without
Ca2+. The signal is very similar to that observed for the normal
glucose group (compare to Figure
1B). Indeed, the peak Ca2+ value after TG treatment in
the presence of extracellular Ca2+ averaged 470 ± 60 nM for
the normal glucose group and 478 ± 54 nM for the chronic high glucose
group (Table 2B), convincingly
demonstrating that the SOCI was not affected by chronic high glucose treatment
(Figure 7). Similarly, in the
absence of extracellular Ca2+, the peak Ca2+ values did
not differ between the two groups even though there was a tendency for the
mean change to be smaller in the presence of chronic glucose
(Table 2). (Note that this lack
of a chronic affect is fully consistent with that observed for the effects of
acute high glucose levels on Ca2+ release ; see
Table 1.) These results provide
strong evidence that neither chronic high glucose levels nor acute high
glucose levels alter intracellular calcium stores and the release of calcium
from these stores.
|
Do Ca2+ Signals Adapt to High Glucose Levels ?
The determine whether the Ca2+ signaling pathways adapt to
chronic high glucose levels, cells were cultured in high glucose media (30 mM)
for 5 to 7 d, but then tested in normal glucose media (5 mM) (30G : 5G group).
Figure 8, A and B, shows
typical traces for ET-induced and TG-induced Ca2+ signaling. In
Figure 8A, the ET-induced
Ca2+ signal in the presence of extracellular Ca2+
approaches 650 nM, equal to or exceeding the Ca2+ signal in cells
cultured and tested in normal glucose media (compare to
Figure 1A). Similarly, the
TG-induced Ca2+ signal appears equivalent to that observed for
cells cultured and tested in normal glucose media (compare to
Figure 1B) and shows no
evidence of being depressed (Figure
1B). Therefore, both acute and chronic elevations of glucose
depress the ET-induced Ca2+ influx, but this depression is readily
and rapidly reversed upon restoration of normal glucose levels, demonstrating
little or no adaptation of the Ca2+ signaling pathways to high
glucose, at least not over the 5- to 7-d treatment period.
|
| Discussion |
|---|
|
|
|---|
The hypocontractile response of mesangial cells to vasoactive substances has been shown for cells from diabetic animals as well as for cells from nondiabetic animals, but where the extracellular glucose levels were chronically elevated above normal (5,12). It has been suggested that the contractile elements themselves may undergo rearrangement and lead to an altered ability of these cells to contract (12). However, there is accumulating evidence that Ca2+ signaling induced by vasoactive agents, in general, is depressed in cells exposed to elevated glucose levels and that this may contribute to the hypocontractile responsiveness of these cells. Indeed, it has been shown that vasoactive substances, notably AngII, noradrenaline, prostaglandin (PGF2a), and arginine vasopressin (AVP), elicit significantly reduced [Ca2+]i transients in high glucose (22 mM) media compared to normal (5.5 mM) conditions (8,9,10). Indeed, the present study demonstrates that high glucose levels similarly depress the ET-induced [Ca2+]i transients. Furthermore, the present study shows that the effect of high glucose was to depress the ET-induced calcium entry into the cells, a finding similar to that observed by Mene and coworkers for the actions of AngII (11). However, although these later investigators attributed the affects of high glucose on calcium influx to inhibition of SOCI, the results of the present study using ET convincingly demonstrate that the depressant action of elevated glucose levels are not due to inhibition of SOCI, but rather are due to inhibition of an apparent receptor-operated Ca2+ influx pathway operating in parallel to the SOCI pathway (see below).
It should be noted, however, that not all reports support the concept of a glucose-dependent Ca2+ signal in mesangial cells. In studies from one group, it was reported that Ca2+ signals induced by vasoactive peptides (AngII, ET, AVP) were not altered in the presence of elevated glucose levels (5,10), although the cells were shown to have a hypocontractile response. The reason for this difference from that observed in the current studies and those of others, as heretofore mentioned, is not known, but could be related to the culture passage of the cells used in the studies (culture passage 15 to 40 versus 3 to 15 in the current study) or the higher concentrations of vasoactive substances used (e.g., 100 nM ET versus 10 nM ET in the present study). However, despite these possible factors, responses of cultured mesangial cells to vasoactive peptides are known to be highly variable among individual cells, even if the cells are from the same plating as shown by Kanamori et al. (9) for AngII. We have also noted a reduced but variable responsiveness of cultured mesangial cells to AngII (data not shown). Hence, caution must be exercised in interpreting the quantitative response of cultured mesangial cells to any given stimuli.
Effects of High Glucose on Calcium Release from Internal Calcium
Stores
The transduction pathways underlying the effects of glucose on calcium
signaling are not well defined. Early studies in rat mesangial cells have
focused on a possible role of either the "polyol pathway" or the
DAG/protein kinase C pathway in modulating the PLC/IP3 pathway. It
follows from this assessment that elevated glucose levels should lead to a
depressant effect of vasoactive peptides on the production of IP3
and, in turn, on the resulting changes in [Ca2+]i.
However, such an affect should be associated with a decrease in the release of
calcium from stores and a consequent decrease in SOCI. Our data show that
there were no differences in ET-induced Ca2+ release from internal
stores among normal, acute, and chronic high glucose groups. Likewise, Mene
and coworkers (11) have shown
that the addition of a Ca2+ ionophore to release Ca2+
from internal stores did not affect the amount of releasable Ca2+
in cells cultured in chronic high glucose growth conditions. This implicates a
glucose affect either on a Ca2+ entry pathway that is not linked to
the release of Ca2+ from internal stores, such as receptor-operated
Ca2+ entry, or an effect on a signaling component distal to the
release of Ca2+ from stores.
Effects of High Glucose on Store-Operated and Non-Store-Operated
Calcium Influx
Which Ca2+ influx pathway is inhibited by elevated glucose
levels ? A recent report from Mene and coworkers
(11) implicated a role for
SOCI in this process. However, to more fully address this issue, the present
study focused on assessing the effects of glucose on both SOCI and parallel
entry pathways activated by ET, supposedly receptor-operated Ca2+
influx. It should be noted that these earlier workers measured the effect of
glucose on SOCI by first completely removing all extracellular Ca2+
to deplete internal stores, then monitoring the changes in intracellular
Ca2+ levels upon restoration of extracellular Ca2+
levels to normal. This technique would, by definition, include contributions
to intracellular Ca2+ levels from all active Ca2+ influx
pathways. In the current studies, we attempted to refine this process by
monitoring the changes in intracellular Ca2+ after addition of TG
to unload stores, but where extracellular Ca2+ levels were always
maintained at normal levels. In this way, the changes in intracellular
Ca2+ levels should primarily reflect contributions from SOCI. By
this approach, we were able to demonstrate that the affect of high glucose
levels on Ca2+ influx is not due to alterations in SOCI. Indeed,
SOCI was not altered by either acute or chronic high glucose groups
(Figures 6B and
7B). This is in keeping with
the observations that the ability to release Ca2+ from internal
stores and, hence, the signal to release Ca, were not affected by high
glucose. It follows that neither the PLC/IP3 pathway linked to the
ER, the release of calcium from internal ER stores, nor the SOCI appear to be
responsible for the reduction in calcium influx in the presence of elevated
levels of glucose.
Because SOCI is not altered by elevated glucose levels, the effect of glucose on ET-induced calcium influx must, by definition, reflect changes in a Ca2+ entry pathway parallel to SOCI. This parallel pathway is not likely a voltage-operated Ca2+ entry pathway because ET does not appear to activate voltage-operated Ca2+ channels (24). Hence, this parallel pathway likely reflects a receptor-operated Ca entry pathway that is activated by ET binding to its receptor. However, the effects of ET on Ca signaling are likely to be complex because the ET receptor coupled to PLC (16) will generate IP3, which, in turn, will lead to release of Ca2+ from stores and activation of SOCI. Consequently, since the present study also demonstrates that the ET-induced Ca2+ signal appears to be greater than that induced by maximally releasing Ca2+ from internal stores with TG, an additional component of Ca2+ influx must be activated by ET. It is this newly identified receptor-operated Ca2+ influx pathway that is the component of the Ca2+ signal that appears to be depressed in the presence of elevated glucose levels with little or no affect on SOCI as discussed above (compare Figure 3A with Figure 6A). Hence, it follows that the dominant affect of elevated glucose levels on Ca2+ influx is to depress receptor-operated Ca2+ influx in mesangial cells.
Reversibility of Glucose Effects on the Ca2+ Signal
In the early stages of diabetes, the renal pathology is associated with a
decreased afferent arteriolar resistance and hypocontractility of mesangial
cells. This leads to raised intraglomerular pressure, an important factor
contributing to the pathogenesis of fractional mesangial expansion and
progressive glomerulosclerosis
(1,28).
This state is generally accompained by a chronic elevation in plasma glucose
levels that may contribute to the hypocontractility. Although it is generally
believed that chronic exposure of cells to elevated glucose leads to part of
the pathology, the present studies demonstrate that the effect of elevated
glucose levels on the Ca2+ signal is primarily an acute phenomenon
that does not require chronic exposure to elevated glucose levels. It was
found that both chronic (days) and acute (minutes) exposure of mesangial cells
to elevated glucose levels (30 mM) depressed the ET-induced Ca2+
signal by a similar amount. Most importantly, however, was the demonstration
that when cells were first chronically exposed to high glucose levels for
several days, subsequent acute reduction of the glucose levels to normal (5
mM) for several minutes immediately restores the ET-induced Ca2+
signal to normal. Hence, the effect of elevated glucose levels on the
Ca2+ signal is an acute effect that is readily reversible with no
apparent adaptation of the Ca2+ signaling components to chronically
elevated glucose levels for up to 1 wk. It may be that prolonged chronic
exposure to elevated glucose for several weeks may have additional effects
(29).
Mechanism of High Glucose Effects on Ca2+ Signaling
It would appear from these studies that the effect of elevated glucose on
Ca2+ signaling in mesangial cells is not a generalized phenomenon.
The elevated glucose levels do not appear to affect either the Ca2+
stores (or release from stores) or the SOCI. The depressant effect of glucose
on Ca2+ signaling appears to be solely on a newly unmasked
receptor-operated Ca2+ influx pathway, supposedly a
receptor-operated Ca2+ channel. The mechanism by which this occurs
is currently unknown. It is not likely due to a downregulation of the ET
receptor because the ET-induced release of Ca2+ from stores does
not appear to be affected by high glucose levels, particularly during acute
exposure to high glucose levels (Figure
3B). A lack of an effect of glucose on receptor levels would be in
keeping with the finding of Amiri and Garcia
(29) that treatment of
mesangial cells with high glucose levels for up to 14 d did not affect AngII
receptor levels (longer exposures depressed receptor levels). Hence, the
effect of elevated glucose levels must be on an event downstream from the ET
receptor. Recent studies point to a possible role of DAG, synthesized de
novo from glucose, and protein kinase C redistribution in this process
(27,30).
Other studies have presented evidence for a role of advanced glycation end
products, generated in the presence of high glucose levels, which may
themselves bind to and alter Ca2+ signaling components in mesangial
cells (31). Exactly how these
downstream events may modulate Ca2+ signaling components in
mesangial cells is currently not well understood. Additional studies are
needed to elucidate the various components of the signal transduction pathways
in regulating the Ca2+ transport events and the mechanism by which
these pathways are modulated in the presence of altered glucose levels.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Graham, M. Ding, S. Sours-Brothers, T. Yorio, J.-X. Ma, and R. Ma Downregulation of TRPC6 protein expression by high glucose, a possible mechanism for the impaired Ca2+ signaling in glomerular mesangial cells in diabetes Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1381 - F1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, H. Meng, Z.-H. Li, Z. Shu, X. Ma, and B.-X. Zhang Regulation of STIM1, store-operated Ca2+ influx, and nitric oxide generation by retinoic acid in rat mesangial cells Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1054 - F1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sours, J. Du, S. Chu, M. Ding, X. J. Zhou, and R. Ma Expression of canonical transient receptor potential (TRPC) proteins in human glomerular mesangial cells Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1507 - F1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ma, J. Du, S. Sours, and M. Ding Store-Operated Ca2+ Channel in Renal Microcirculation and Glomeruli Experimental Biology and Medicine, February 1, 2006; 231(2): 145 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Frecker, S. Munk, H. Wang, and C. Whiteside Mesangial cell-reduced Ca2+ signaling in high glucose is due to inactivation of phospholipase C-{beta}3 by protein kinase C Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1078 - F1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ma, J. L. Pluznick, and S. C. Sansom Ion Channels in Mesangial Cells: Function, Malfunction, or Fiction Physiology, April 1, 2005; 20(2): 102 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Facemire, P. J. Mohler, and W. J. Arendshorst Expression and relative abundance of short transient receptor potential channels in the rat renal microcirculation Am J Physiol Renal Physiol, March 1, 2004; 286(3): F546 - F551. [Abstract] [Full Text] |
||||
![]() |
A. Sorokin and D. E. Kohan Physiology and pathology of endothelin-1 in renal mesangium Am J Physiol Renal Physiol, October 1, 2003; 285(4): F579 - F589. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hua, S. Munk, H. Goldberg, I. G. Fantus, and C. I. Whiteside High Glucose-suppressed Endothelin-1 Ca2+ Signaling via NADPH Oxidase and Diacylglycerol-sensitive Protein Kinase C Isozymes in Mesangial Cells J. Biol. Chem., September 5, 2003; 278(36): 33951 - 33962. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Nutt, J. Chandra, A. Pataer, B. Fang, J. A. Roth, S. G. Swisher, R. G. O'Neil, and D. J. McConkey Bax-mediated Ca2+ Mobilization Promotes Cytochrome c Release during Apoptosis J. Biol. Chem., May 31, 2002; 277(23): 20301 - 20308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Dlugosz, S. Munk, E. Ispanovic, H. J. Goldberg, and C. I. Whiteside Mesangial cell filamentous actin disassembly and hypocontractility in high glucose are mediated by PKC-zeta Am J Physiol Renal Physiol, January 1, 2002; 282(1): F151 - F163. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |